TP53 and lung carcinoma: While the underlying causes of the latter remain subjects of substantial debate, emerging evidence indicates that this interdependence forms the foundation for numerous disease-associated mutation spectra, notably that of the TP53 mutation spectrum within the context of lung cancer (Hollstein et al. 1991, Toyooka et al. 2003).